Rakovina Therapeutics AI Cancer Drug Discovery Q3 2024

Rakovina Therapeutics uses Deep Docking AI platform to rapidly screen billions of molecular structures for DNA-damage response-targeted cancer therapies. Founded in 2021, the company leverages advanced algorithms and R&D infrastructure with UBC to accelerate drug discovery and reduce treatment delays that increase mortality risk.